Acumen’s $130 Million Common Stock Public Offering

Pietro Martinoia
Tagged:

Ropes & Gray advised Acumen, and Latham & Watkins advised the underwriters.Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) announced the pricing of an upsized underwritten public offering of 16,774,193…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now